Kezar Life Sciences, Inc. - Current Ratio

The Current Ratio as of June 2026 (TTM) for Kezar Life Sciences, Inc. (KZR) is 24.46

According to Kezar Life Sciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 24.46. This represents a change of 94.39% compared to the average of 12.58 of the last 4 quarters.

Kezar Life Sciences, Inc. (KZR) Historical Current Ratio (quarterly & annually)

How has KZR Current Ratio performed in the past?

The mean historical Current Ratio of Kezar Life Sciences, Inc. over the last ten years is 20.20. The current 24.46 Current Ratio has changed 12.01% with respect to the historical average. Over the past ten years (40 quarters), KZR's Current Ratio was at its highest in in the June 2022 quarter at 39.64. The Current Ratio was at its lowest in in the March 2017 quarter at 0.

Kezar Life Sciences, Inc. (KZR) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Kezar Life Sciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Kezar Life Sciences, Inc. (KZR) Average Current Ratio

How has KZR Current Ratio performed in the past?

The current Current Ratio of Kezar Life Sciences, Inc. (KZR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Kezar Life Sciences, Inc. (KZR) Current Ratio vs. Peers

How is KZR’s Current Ratio compared to its peers?

Kezar Life Sciences, Inc.’s Current Ratio is greater than Tempest Therapeutics, Inc. (0.74), greater than FibroGen, Inc. (3.61), greater than OnKure Therapeutics, Inc. (13.78), greater than Aligos Therapeutics, Inc. (2.56), greater than Mersana Therapeutics, Inc. (1.39), greater than Barinthus Biotherapeutics plc (6.05), greater than PDS Biotechnology Corporation (2.26), greater than X4 Pharmaceuticals, Inc. (10.18), greater than Xilio Therapeutics, Inc. (3.59), greater than Actinium Pharmaceuticals, Inc. (5.89),

Build a custom stock screener for Kezar Life Sciences, Inc. (KZR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kezar Life Sciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kezar Life Sciences, Inc. (KZR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kezar Life Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.